Discover the full insider trade history of Ascendis Pharma A/S, a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €13.2bn. The latest transaction was disclosed on 2 June 2026 (Acquisition). Among the most active insiders: BIENAIME JEAN JACQUES. The full history is accessible without an account.
8
Insider Decl.
0
Thresholds
€244,721
7 ops.
Buy Volume
€4m
1 ops.
Sell Volume
42Σ signal
Buys €244,721€4m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.